TIL therapy uses tumor-infiltrating lymphocytes collected from a patient’s tumor, expanded in the laboratory and infused back into the patient. It is a personalized cellular immunotherapy. Approved cellular products are available for selected settings in metastatic melanoma, while use in other solid tumors remains under active investigation.